Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brecht Steelant

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Translational Allergy|July 15, 2017
Endotype-driven treatment in chronic upper airway diseasesGlynnis De Greve, Peter W Hellings, Wytske J Fokkens, et al.
Allergy|December 7, 2020
Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patientsIna Callebaut, Brecht Steelant, Wout Backaert, et al.
JACC. Cardiovascular Imaging|April 18, 2016
The Impact of Infarct Location and Extent on LV Motion Patterns: Implications for Dyssynchrony AssessmentBrecht Steelant, Ivan Stankovic, Ine Roijakkers, et al.
Allergy|August 21, 2021
Self-reported nasal hyperreactivity is common in all chronic upper airway inflammatory phenotypes and not related to general well-beingWout Backaert, Brecht Steelant, Mark Jorissen, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2024
The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitisEmma Ruysseveldt, Brecht Steelant, Tine Wils, et al.
The World Allergy Organization Journal|September 27, 2021
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitisMaria Doulaptsi, Tine Wils, Peter W Hellings, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 22, 2020
Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrityKatleen Martens, Sven F Seys, Yeranddy A Alpizar, et al.
American Journal of Rhinology & Allergy|September 9, 2014
Nasal allergen deposition leads to conjunctival mast cell degranulation in allergic rhinoconjunctivitisIna Callebaut, Annick De Vries, Brecht Steelant, et al.
The Journal of Allergy and Clinical Immunology|May 23, 2020
Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: A randomized, double-blind, placebo-controlled trialLaura Van Gerven, Brecht Steelant, Leen Cools, et al.
Allergy|November 27, 2019
Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammationInge Kortekaas Krohn, Sven F Seys, Gitte Lund, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Translational Allergy|July 15, 2017
Endotype-driven treatment in chronic upper airway diseasesGlynnis De Greve, Peter W Hellings, Wytske J Fokkens, et al.
Allergy|December 7, 2020
Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patientsIna Callebaut, Brecht Steelant, Wout Backaert, et al.
JACC. Cardiovascular Imaging|April 18, 2016
The Impact of Infarct Location and Extent on LV Motion Patterns: Implications for Dyssynchrony AssessmentBrecht Steelant, Ivan Stankovic, Ine Roijakkers, et al.
Allergy|August 21, 2021
Self-reported nasal hyperreactivity is common in all chronic upper airway inflammatory phenotypes and not related to general well-beingWout Backaert, Brecht Steelant, Mark Jorissen, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2024
The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitisEmma Ruysseveldt, Brecht Steelant, Tine Wils, et al.
The World Allergy Organization Journal|September 27, 2021
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitisMaria Doulaptsi, Tine Wils, Peter W Hellings, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 22, 2020
Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrityKatleen Martens, Sven F Seys, Yeranddy A Alpizar, et al.
American Journal of Rhinology & Allergy|September 9, 2014
Nasal allergen deposition leads to conjunctival mast cell degranulation in allergic rhinoconjunctivitisIna Callebaut, Annick De Vries, Brecht Steelant, et al.
The Journal of Allergy and Clinical Immunology|May 23, 2020
Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: A randomized, double-blind, placebo-controlled trialLaura Van Gerven, Brecht Steelant, Leen Cools, et al.
Allergy|November 27, 2019
Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammationInge Kortekaas Krohn, Sven F Seys, Gitte Lund, et al.
Pageof 4